First Heartland Consultants’s iShares Biotechnology ETF IBB Stock Holding History

First Heartland Consultants’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,610	Closed	-$245	–	376
2021 Q4	$245	Buy	+1,610	New	+$249K	0.01%	318
2018 Q1	–	Sell	-7,884	Closed	-$842K	–	269
2017 Q4	$842K	Sell	7,884 -336	-4%	-$35.9K	0.25%	99
2017 Q3	$914K	Sell	8,220 -180	-2%	-$19.2K	0.22%	131
2017 Q2	$868K	Sell	8,400 -285	-3%	-$28.1K	0.23%	125
2017 Q1	$849K	Sell	8,685 -117	-1%	-$11.2K	0.24%	123
2016 Q4	$779K	Buy	+8,802	New	+$801K	0.24%	117

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Heartland Consultants's IBB Position: Q1 2022 in Review

First Heartland Consultants sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,610 shares — an estimated $245 sold.

First Heartland Consultants first reported a position in IBB in Q4 2016 and held it in 6 quarters. The position peaked at $914K in Q3 2017. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

First Heartland Consultants reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
First Heartland Consultants sold 1,610 iShares Biotechnology ETF shares in Q1 2022, an estimated $245.
First Heartland Consultants first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 6 quarters.
First Heartland Consultants's iShares Biotechnology ETF position peaked at $914K in Q3 2017.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on First Heartland Consultants's 13F filing for Q1 2022, filed 21 Apr 2022.